June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Suppression of Corneal Angiogenesis by Toll-like Receptors
Author Affiliations & Notes
  • Lei Liu
    Dept of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
  • Jiahui Wu
    Dept of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
  • Andrew Dick
    Dept of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
  • Footnotes
    Commercial Relationships Lei Liu, None; Jiahui Wu, None; Andrew Dick, Novartis (C), Novartis (F), GSK (F), Abbott (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2089. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Lei Liu, Jiahui Wu, Andrew Dick; Suppression of Corneal Angiogenesis by Toll-like Receptors. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2089.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To investigate whether TLR activation regulates corneal hem- and lymph-angiogenesis.

Methods: B6LY5 mice aortic ring explants were cultured for 5 d with the presence of 10ng/mL VEGF before TLR ligands 1-9 were added into culture media. Sprouting outgrowth was measured and compared between TLR ligands treated groups and water treated control group after 5 further days of culture. Corneal angiogenesis was induced by 3 Nylon corneal sutures on BALB/c mice before water, TLR3, TLR7 or TLR9 ligand was applied topically on debrided cornea at day 0, day 2, and day 4. The corneal vessel ingrowth was scored under surgical microscope after 7 days. The volumes of blood and lymphatic corneal vessels were quantified after whole mount immunofluorescence staining with CD31 and LYVE-1 antibodies.

Results: TLR7 and TLR9 activation suppressed vascular outgrowth from aortic ring explants compared to control. TLR9 engagement inhibited corneal blood vessel ingrowth after 7 d post corneal suturing, while there was no difference between control and TLR3 and TLR7 treatment groups. TLR9 activation also decreased the volumes of blood and lymphatic corneal vessels compared to control.

Conclusions: TLR9 activation could suppress aortic vessel sprouting in vitro as well as corneal hem- and lymph-angiogenesis in vivo.

Keywords: 480 cornea: basic science • 557 inflammation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×